Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
lignin hydrolytic
- Development stage
- Phase 3
- Lead developer
- Avva Rus
- Modality
- Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Administration
- Oral
01
Overview
Lignin hydrolytic is a natural enterosorbent, a type of intestinal adsorbent, derived from wood hydrolysis products. It is a high-molecular-weight polymer with a porous structure, resistant to metabolic breakdown by gastrointestinal enzymes. It functions by binding and eliminating various toxins, pathogenic microorganisms, and viruses from the gastrointestinal tract. Additionally, it sorbs excess metabolic products such as cholesterol, bilirubin, and urea. The drug is non-toxic, inoffensive to mucous membranes, enhances colonic propulsion, and improves natural microflora. It is manufactured by Avva Rus, JSC.
- Brand names
- Filtrum-STIFiltrum
- Other names
- Lignin Hydrolysed
Beyond the preview
Go deeper on lignin hydrolytic.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on lignin hydrolytic.